
Munchen [Germany]: Researchers at LMU have successfully tested a novel medication that can greatly prolong the lives of patients with breast cancer.
Brain metastases are frequently observed in patients with advanced HER2-positive breast cancer. Patients who experience this have little likelihood of surviving the following few years while receiving current treatments like radiotherapy and surgery.